NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Software - Application · USD

Firefly Neuroscience, Inc. (AIFF) Stock Analysis

Firefly Neuroscience, Inc. (AIFF) is a Software - Application stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

AIFF

$1.05

−$0.02 (−1.42%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AIFF with… →

AIFF Key Statistics

As of Oct 21, 2026
Trading
Open
$1.07
Previous Close
$1.06
Day's Range
1.03–1.09
52-Week Range
0.62–3.15
Volume
47.36K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−4.04
Valuation
Market Cap
$16.40M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
9.11
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.59
Financials (FY)
Revenue (FY)
$1.14M+957.41%
Net Income (FY)
−$19.88M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
15.69M
1-Year Return
−55.53%
Dividend and dates
Avg Volume
2.68M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AIFF closed at $1.05, −55.53% over 1 year.

Firefly Neuroscience, Inc. (AIFF) has a market capitalization of $16.40M.

In fiscal 2025, AIFF reported revenue of $1.14M.

AIFF Stock Return by Calendar Year

Firefly Neuroscience, Inc. (AIFF) 10-year return: what $10,000 became

1 year
$10,000 $4,447
−55.53%
5 years
$10,000 $97
−99.03%
10 years
$10,000 $2,322
−76.78%

If you had invested $10,000 in Firefly Neuroscience, Inc. (AIFF) 10 years ago, at the close on October 21, 2016, it would have been worth $2,322 at the close on October 21, 2026: −76.78% in total, −13.58% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+18.75%
2025−66.79%
2024−47.73%
2023−64.79%
2022−90.30%
2021+241.38%
2020+1,015.38%
2019−7.14%
2018−66.67%
2017+250.00%
2016 (partial year)−25.00%

As of October 21, 2026.

AIFF Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.14M−$19.88M−1,741.0%
2024$108.00K−$10.46M−9,685.2%
2023$498.00K−$2.60M−522.7%
2022$0.00−$3.79M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.14M$645.00K−$8.61M−$19.88M−1,741.0%
2024$108.00K$108.00K−$9.18M−$10.46M−9,685.2%
2023$498.00K$498.00K−$3.08M−$2.60M−522.7%
2022$0.00$0.00−$3.25M−$3.79M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AIFF Valuation vs Software - Application Median

Median of 240 stocks
MetricAIFFSoftware - Application medianvs median
P/S ratio9.112.833.2x the median

Medians across 240 Software - Application stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Firefly Neuroscience, Inc. (AIFF) carries a market capitalisation of $16.40M. It is classified in the Software - Application industry, within the Technology sector. Headcount on file is 17.

AIFF last closed at $1.05 on October 21, 2026. That is −$0.02 (−1.42%) against the previous close. Over the past 52 weeks the price has ranged from $0.62 to $3.15. The latest close sits 68.55% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.14M. Against the prior fiscal year total of $108.00K, that is a change of +957.41%. The same year closed with a net loss of $19.88M. Earnings per share on a trailing basis come to −0.59.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $1.14M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 9.11. On price-to-sales that is 3.2 times the Software - Application median of 2.83. 240 Software - Application companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at −4.04. Annualized volatility over the trailing 10 years is 154.67%. The trailing one-year total return is −55.53%. Measured over 10 years, that is −13.58% a year compounded.

Growth & Income

The record shows no dividend for AIFF.

The strongest complete calendar year on file is 2020 at +1,015.38%; the weakest is 2022 at −90.30%. Of the 9 complete calendar years on file, 3 finished higher. 2026 is still running; the total return is +18.75% year to date.

Peer Comparison

Firefly Neuroscience, Inc. (AIFF) operates in the Software - Application industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Firefly Neuroscience, Inc. AIFF $16.40M —
SAP SE SAP $268.62B 29.9
Shopify Inc. SHOP $226.17B 117.8
Salesforce, Inc. CRM $198.98B 22.1

The Software - Application industry average P/E ratio is 29.8x. Firefly Neuroscience, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Software - Application Stocks

SAP

SAP SE

$268.62B

 SHOP

Shopify Inc.

$226.17B

 CRM

Salesforce, Inc.

$198.98B

 NOW

ServiceNow, Inc.

$158.30B

 UBER

Uber Technologies, Inc.

$138.12B

 ADP

Automatic Data Processing, Inc.

$116.70B
View all Software - Application stocks →

Popular Technology Stocks

NVDA

NVIDIA Corporation

$5.36T

 AAPL

Apple Inc.

$5.02T

 MSFT

Microsoft Corporation

$3.96T

 TSM

Taiwan Semiconductor Manufacturing Company Limited

$2.24T

 AVGO

Broadcom Inc.

$1.61T
View all Technology stocks →

About Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Visit website →